ARCHIVES

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

This article is from The Cancer Letter archive.

Vol. 34 No. 31 | August 8, 2008

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012